Furthermore, we demonstrate that PRMT2-depleted AML cells exhibit heightened activation of the NF-κB signaling pathway, leading to IL6 overexpression, and ultimately to an increased phosphorylation of the STAT3 protein. The gene discussed is NFKB1; the disease is acute myeloid leukemia.